1. Home
  2. APLT vs FWRG Comparison

APLT vs FWRG Comparison

Compare APLT & FWRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • FWRG
  • Stock Information
  • Founded
  • APLT 2016
  • FWRG 1983
  • Country
  • APLT United States
  • FWRG United States
  • Employees
  • APLT N/A
  • FWRG N/A
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • FWRG Restaurants
  • Sector
  • APLT Health Care
  • FWRG Consumer Discretionary
  • Exchange
  • APLT Nasdaq
  • FWRG Nasdaq
  • Market Cap
  • APLT 63.6M
  • FWRG 970.4M
  • IPO Year
  • APLT 2019
  • FWRG 2021
  • Fundamental
  • Price
  • APLT $0.41
  • FWRG $16.53
  • Analyst Decision
  • APLT Buy
  • FWRG Strong Buy
  • Analyst Count
  • APLT 6
  • FWRG 10
  • Target Price
  • APLT $6.10
  • FWRG $22.20
  • AVG Volume (30 Days)
  • APLT 771.9K
  • FWRG 1.1M
  • Earning Date
  • APLT 11-06-2025
  • FWRG 11-06-2025
  • Dividend Yield
  • APLT N/A
  • FWRG N/A
  • EPS Growth
  • APLT N/A
  • FWRG N/A
  • EPS
  • APLT N/A
  • FWRG 0.06
  • Revenue
  • APLT $121,000.00
  • FWRG $1,105,027,000.00
  • Revenue This Year
  • APLT N/A
  • FWRG $22.16
  • Revenue Next Year
  • APLT $5,931.24
  • FWRG $16.20
  • P/E Ratio
  • APLT N/A
  • FWRG $280.47
  • Revenue Growth
  • APLT N/A
  • FWRG 14.53
  • 52 Week Low
  • APLT $0.30
  • FWRG $12.90
  • 52 Week High
  • APLT $10.62
  • FWRG $22.71
  • Technical
  • Relative Strength Index (RSI)
  • APLT 38.50
  • FWRG 35.37
  • Support Level
  • APLT $0.40
  • FWRG $16.98
  • Resistance Level
  • APLT $0.46
  • FWRG $17.83
  • Average True Range (ATR)
  • APLT 0.03
  • FWRG 0.62
  • MACD
  • APLT -0.01
  • FWRG -0.25
  • Stochastic Oscillator
  • APLT 7.74
  • FWRG 3.68

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About FWRG First Watch Restaurant Group Inc.

First Watch Restaurant Group Inc is a daytime restaurant concept serving made-to-order breakfast, brunch, and lunch using fresh ingredients. It generates revenues from Restaurant sales and Franchise revenues.

Share on Social Networks: